Psychotherapeutic interventions in the treatment of comorbid psychological disorders in multiple sclerosis;Psychotherapie komorbider psychischer störungen bei MS

Neurologie und Rehabilitation

Volumn 12, Issue 4, 2006, Pages 214-223

  Schmidt, Roger ^a   Krauss B ^a   Weiss M ^a  

^a Kliniken Schmieder Konstanz und Gailingen   (Germany)

Author keywords

Integrated psychotherapy; Multiple sclerosis; Psychiatric comorbidity; Somato psycho somatic

Indexed keywords

PSYCHOTROPIC AGENT;

ANXIETY; COMORBIDITY; COPING BEHAVIOR; DEPRESSION; FATIGUE; GUILT; HUMAN; MENTAL DISEASE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGY; PAIN; PATIENT EDUCATION; PATIENT INFORMATION; PSYCHOPHARMACOTHERAPY; PSYCHOSOMATIC DISORDER; PSYCHOTHERAPY; REVIEW; SHAME; SOMATOFORM DISORDER; STRESS; SUICIDE;

EID: 33750321265     PISSN: 09472177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Aldridge D, Schmid W, Kaeder M, Schmidt C, Ostermann T: Functionality or aesthetics? A pilot study of music therapy in the treatment of multiple sclerosis patients. Complement Ther Med 2005; 13: 25-33
2. Allanson J, Bass C, Wade DT: Characteristics of patients with persistent severe disability and medically unexplained neurological symptoms: a pilot study. J Neurol Neurosurg Psychiatry 2002; 73: 307-309
3. Apel A, Klauer T, Zettl UK: Stress und Krankheitsverlauf der Multiplen Sklerose. Fortschr Neurol Psychiatr 2006; DOI: 10.1055/s-2005-919090
4. Arciniegas DB, Anderson CA: Suicide in neurologic illness. Current Treatment Options in Neurology 2002; 4: 457-468
5. Arnett PA, Randolph JJ: Longitudinal course of depression symptoms in multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77: 606-610
6. Arnett PA, Higginson CI, Voss WD, Randolph JJ, Grandey AA: Relationship between coping, cognitive dysfunction and depression in multiple sclerosis. Clin Neuropsychol 2002; 16: 341-355
7. Becker H: Psychotische Symptome als Erstmanifestation der Multiplen Sklerose? Psychiatr Prax 1997; 24: 69-72
8. Benrud-Larson LM, Wegener ST: Chronic pain in neurorehabilitation populations: Prevalence, severity and impact. NeuroRehabilitation 2000; 14: 127-137
9. Bensing JM, Hulsman RL, Schreurs KM: Gender differences in fatigue: biopsychosocial factors relating to fatigue in men and women. Med Care 1999; 37: 1078-1083
10. Boeije HR, Duijnstee MS, Grypdonck MH, Pool A: Encountering the downward phase: biographical work in people with multiple sclerosis living at home. Soc Sci Med 2002; 55: 881-893
11. Borello-France D, Leng W, O'Leary M, Xavier M, Erickson J, Chancellor MB, Cannon TW: Bladder and sexual function among women with multiple sclerosis. Mult Scler 2004; 10: 455-461
12. Bronnum-Hansen H, Stenager E, Nylev Stenager E, Koch-Henriksen N: Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 1457-1459
13. Buljevac D, Hop WC, Reedeker W, Janssens AC, van der Meche FG, van Doorn PA et al: Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. BMJ 2003; 327: 646
14. Caplan LR, Nadelson T: Multiple sclerosis and hysteria. Lessons learned from their association. JAMA 1980; 243: 2418-2421
15. Chwastiak LA, Gibbons LE, Ehde DM, Sullivan M, Bowen JD, Bombardier CH, et al: Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. J Psychosom Res 2005; 59: 291-98
16. Courts NF, Newton AN, McNeal LJ: Husbands and wives living with multiple sclerosis. J Neurosci Nurs 2005; 37: 20-27
17. Crawford JD, McIvor GP: Group psychotherapy: benefits in multiple sclerosis. Arch Phys Med Rehabil 1985; 66: 810-813
18. Crayton H, Heyman RA, Rossman HS: A multimodal approach to managing the symptoms of multiple sclerosis. Neurology 2004; 63: S12-8
19. Demirkiran M, Sarica Y, Uguz S, Yerdelen D, Aslan K: Multiple sclerosis patients with and without sexual dysfunction: are there any differences? Mult Scler 2006; 12: 209-214
20. Evans JJ, Levine B, Bateman A: Research Digest Fatigue. Neuropsychological Rehabilitation 2006; 16: 110-114
21. Feinstein A, Feinstein K: Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression. J Affect Disord 2001; 66: 193-198
22. Feinstein A, O'Connor P, Gray T, Feinstein K: The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler 1999; 5: 323-326
23. Feinstein A: An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002; 59: 674-678
24. Fishman I, Benedict RH, Bakshi R, Priore R, Weinstock-Guttman B: Construct validity and frequency of euphoria sclerotica in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2004; 16: 350-356
25. Fisk JD, Morehouse SA, Brown MG, Skedgel C, Murray TJ: Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci 1998; 25: 230-235
26. Fournier M, de Ridder D, Sensing J: Optimism and adaptation to chronic disease: The role of optimism in relation to self-care options of type 1 diabetes mellitus, rheumatoid arthritis and multiple sclerosis. British Journal of Health Psychology 2002; 7: 409-432
27. Fredrikson S, Cheng Q, Jiang GX, Wasserman D: Elevated suicide risk among patients with multiple sclerosis in Sweden. Neuroepidemiology 2003; 22: 146-152
28. Galimberti U: La casa di piche. Dalla psicanalisi alla pratica filosfica. Feltrinelli, Milano 2005, 16-19
29. Geronemus DF: The role of the social worker in the comprehensive long-term care of multiple sclerosis patients. Neurology 1980; 30: 48-54
30. Glick ID: Adding psychotherapy to pharmacotherapy: data, benefits, and guidelines for integration. Am J Psychother 2004; 58: 186-208
31. Goeb JL, Even C, Nicolas G, Gohier B, Dubas F, Garre JB: Psychiatric side effects of interferon-beta in multiple sclerosis. Eur Psychiatry 2006; 21: 186-193
32. Gold SM, Mohr DC, Huitinga I, Flachenecker P, Sternberg EM, Heesen C: The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol 2005; 26: 644-652
33. Goverover Y, Chiaravalloti N, DeLuca J: The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Mult Scler 2005; 11: 203-212
34. Grau A, Henningsen P: In: Henningsen P, Gundel H, Ceballos-Baumann A (eds): Neuro-Psychosomatik. Grundlagen und Klinik neurologischer Psychosomatik. Schattauer, Stuttgart/New York 2006: 283-293
35. Haberfellner EM, Markut H: Patientenaufklärung bei Multipler Sklerose: Erfahrungen und Wünsche Betroffener. Wien Med Wochenschr 1995; 145: 218-222
36. Hankey GJ, Stewart-Wynne EG: Pseudo-multiple sclerosis: a clinico-epidemiological study. Clin Exp Neurol 1987; 24: 11-19
37. Helmchen H: Unterschwellige psychische Störungen. Nervenarzt 2001; 72: 181-189
38. Herndon RM: Multiple sclerosis mimics. Adv Neurol 2006; 98: 161-166
39. Janssens AC, van Doom PA, de Boer JB, van der Meche FG, Passchier J, Hintzen RQ: Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand 2003; 108: 389-395
40. Jiwa TI: Multiple sclerosis and self esteem. Axone 1995: 16: 87-90
41. Johnson J: On receiving the diagnosis of multiple sclerosis: managing the transition. Mult Scler 2003; 9: 82-88
42. Johnson KL, Yorkston KM, Klasner ER, Kuehn CM, Johnson E, Amtmann D: The cost and benefits of employment: a qualitative study of experiences of persons with multiple sclerosis. Arch Phys Med Rehabil 2004; 85: 201-209
43. Jopson NM, Moss-Morris R: The role of illness severity and illness representations in adjusting to multiple sclerosis. J Psychosom Res 2003; 54: 503-511; discussion: 513-514
44. Kerns RD, Kassirer M, Otis, J: Pain in multiple sclerosis: a biopsychosocial perspective. J Rehabil Res Dev 2002; 39: 225-232
45. King KE, Arnett PA: Predictors of dyadic adjustment in multiple sclerosis. Mult Scler 2005; 11: 700-707
46. Kleespies PM, Hughes DH, Gallacher FP: Suicide in the medically and terminally ill: psychological and ethical considerations. J Clin Psychol 2000; 56: 1153-1171
47. Kralik D, Koch T, Eastwood S: The salience of the body: transition in sexual self-identity for women living with multiple sclerosis. J Adv Nurs 2003; 42: 11-20
48. Landoni MG, Giordano MT, Guidetti GP: Group psychotherapy experiences for people with multiple sclerosis and psychological support for families. J Neurovirol 2000; 6 (Suppl 2): S168-171
49. Lengdobler H, Kiessling WR: Gruppenmusiktherapie bei multipler Sklerose: Ein erster Erfahrungsbericht. Psychother Psychosom Med Psychol 1989; 39: 369-373
50. Levin N, Mor M, Ben-Hur T: Patterns of misdiagnosis of multiple sclerosis. Isr Med Assoc J 2003; 5: 489-490
51. Leyhe T, Laske C, Buchkremer G, Wormstall H, Wiendl H: Demenz als Erstsymptom bei spät beginnender Multipler Sklerose. Fallserie mit Literaturübersicht. Nervenarzt 2005; 76: 748-755
52. Li J, Johansen C, Bronnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J: The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark. Neurology 2004; 62: 726-729
53. Lopez-Meza E, Corona-Vazquez T, Ruano-Calderon LA, Ramirez-Bermudez J: Severe impulsiveness as the primary manifestation of multiple sclerosis in a young female. Psychiatry Clin Neurosci 2005; 59: 739-742
54. Lynch SG, Kroencke DC, Denney DR: The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope. Mult Scler 2001; 7: 411-416
55. Marcus J, Elkins G, Mott, F: A model of hypnotic intervention for palliative care. Adv Mind Body Med 2003; 19: 24-27
56. Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P: Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult Scler 2005; 11: 592-601
57. McCabe MP, De Judicibus M: The effects of economic disadvantage on psychological well-being and quality of life among people with multiple sclerosis. J Health Psychol 2005; 10: 163-173
58. McCabe MP: Mood and self-esteem of persons with multiple sclerosis following an exacerbation. J Psychosom Res 2005; 59: 161-166
59. Messmer Uccelli M, Mancuso Mohr L, Battaglia MA, Zagami P, Mohr DC: Peer support groups in multiple sclerosis: current effectiveness and future directions. Mult Scler 2004; 10: 80-84
60. Mills N, Allen J: Mindfulness of movement as a coping strategy in multiple sclerosis. A pilot study. Gen Hosp Psychiatry 2000; 22: 425-431
61. Minden SL: Mood disorders in multiple sclerosis: diagnosis and treatment. J Neurovirol 2000; 6 (Suppl 2): 160-167
62. Mohr DC, Dick LP: Multiple Sclerosis. In: Camic P, Knight S (eds): Clinical handbook of health psychology. Hogrefe & Huber, Seattle 1998, 313-348
63. Mohr DC, Pelletier D: A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain Behav Immun 2006; 20: 27-36
64. Mohr DC, Classen C, Barrera MJ: The relationship between social support, depression and treatment for depression in people with multiple sclerosis. Psychol Med 2004; 34: 533-541
65. Mohr DC, Cox D, Merluzzi N: Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications. Mult Scler 2005; 11: 182-185
66. Mohr DC, Epstein L, Luks TL, Goodkin D, Cox D, Goldberg A, et al: Brain lesion volume and neuropsychological function predict efficacy of treatment for depression in multiple sclerosis. J Consult Clin Psychol 2003; 71: 1017-1024
67. Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP: Treatment of depression is associated with suppression of non-specific and antigen-specific T(H)1 responses in multiple sclerosis. Arch Neurol 2001; 58: 1081-1086
68. Mohr DC, Hart SL, Goldberg A: Effects of treatment for depression on fatigue in multiple sclerosis. Psychosomatic Medicine 2003; 65: 542-547
69. Mohr DC, Hart SL, Fonareva I, Tasch ES: Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler 2006; 12: 204-208
70. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D: Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004; 328: 731
71. Morgan JC, Hughes M, Figueroa RE, Sethi KD: Psychogenic paroxysmal dyskinesia following paroxysmal hemidystonia in multiple sclerosis. Neurology 2005; 65: E12
72. Multiple Sklerose Therapie Konsensus Gruppe der Deutschen Multiple Sklerose Gesellschaft: Symptomatische Therapie der Multiplen Sklerose. Nervenarzt 2004: Suppl 1
73. Ostermann T, Schmid W: Music therapy in the treatment of multiple sclerosis: a comprehensive literature review. Expert Rev Neurother 2006; 6: 469-477
74. Pavlou M, Stefoski D: Development of somatizing responses in multiple sclerosis. Psychother Psychosom 1983; 39: 236-243
75. Philippopoulos GS, Wittkower ED, Cousineau A: The etiologic significance of emotional factors in onset and exacerbations of multiple sclerosis. A Preliminary Report. Psychosomatic Medicine 1958; 20: 458-474
76. Polliack ML, Barak Y, Achiron A: Late-onset multiple sclerosis. J Am Geriatr Soc 2001; 49: 168-171
77. Schmidt EZ, Hofmann P, Niederwieser G, Kapfhammer HP, Bonelli RM: Sexuality in multiple sclerosis. J Neural Transm 2005; 112: 1201-1211
78. Schmidt R, Berger M: In: Wallesch C-W (ed): Neurologie. Diagnostik und Therapie in Klinik und Praxis. Elsevier, Urban und Fischer, München/Jena 2005, 1065-1073
79. Schmidt R, Löttgen J, Lütgehetmann R: Chronizität und chronifiziertes Krankheitsverhalten: Die pragmatische Integration medizinisch-somatischer und psychosomatisch-psycho-sozialer Ansätze als Ausgangspunkt erneuter Entwicklung. Praxis der Klinischen Verhaltensmedizin und Rehabilitation 1995; 8: 193-197
80. Schreurs KM, de Ridder DT, Bensing JM: Fatigue in multiple sclerosis: reciprocal relationships with physical disabilities and depression. J Psychosom Res 2002; 53: 775-781
81. Schüßler G: Krankheitsbewältigung und Psychotherapie bei körperlichen und chronischen Erkrankungen. Psychotherapeut 1998; 43: 382-390
82. Siegert RJ, Abernethy DA: Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005; 76: 469-475
83. Sinclair VG, Scroggie J: Effects of a cognitive-behavioural program for women with multiple sclerosis. J Neurosci Nurs 2005; 37: 249-257, 276
84. Steck B, Amsler F, Schwald-Dillier A, Grether A, Kappos L, Burgin D: Indication for psychotherapy in offspring of a parent affected by a chronic somatic disease (e.g. multiple sclerosis). Psychopathology 2005; 38: 38-48
85. Stenager E, Stenager EN, Knudsen L, Jensen K: Multiple sclerosis: the impact on family and social life. Acta Psychiatr Belg 1994; 94: 165-174
86. Stern M: Aging with multiple sclerosis. Phys Med Rehabil Clin N Am 2005; 16: 219-234
87. Stone J, Smyth R, Carson A, Lewis S, Prescott R, Warlow C, et al: Systematic review of misdiagnosis of conversion symptoms and »hysteria«. BMJ 2005: doi:10.1136/bmj.38628.466898.55
88. Strenge H: Multiple Sklerose. In: Ahrens S, Hasenbring M, Schultz-Venrath U, Strenge H (eds): Psychosomatik in der Neurologie. Schattauer, Stuttgart 1995, 295-335
89. Sutherland G, Andersen MB, Morris T: Relaxation and health-related quality of life in multiple sclerosis: the example of autogenic training. J Behav Med 2005; 28: 249-256
90. Tesar N, Baumhackl U, Kopp M, Gunther V: Effects of psychological group therapy in patients with multiple sclerosis. Acta Neurol Scand 2003; 107: 394-399
91. Thomas PW, Thomas S, Hillier C, Galvin K, Baker R: Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev 2006: CD004431
92. Tremlett HL, Luscombe DK, Wiles CM: Prescribing for multiple sclerosis patients in general practice: a case-control study. J Clin Pharm Ther 2001; 26: 437-444
93. Visschedijk MA, Collette EH, Polman CH, Pfennings LE, van der Ploeg HM: Development of a cognitive behavioral group intervention programme for patients with multiple sclerosis: an exploratory study. Psychol Rep 2004; 95: 735-746
94. Vleugels L, Pfennings L, Pouwer F, Cohen L, Ketelaer P, Polman C, et al: Psychological functioning in primary progressive versus secondary progressive multiple sclerosis. Br J Med Psychol 1998; 71: 99-106
95. Wilkening A, Haltenhof H: Psychische Störungen als Begleiterkrankung der multiplen Sklerose. Dtsch Med Wochenschr 2006; 131: 154-158